Cerus Announces the Inclusion of Pathogen Reduction Technology in FDA’s Revised Guidance Document on Bacterial Safety Standards for Platelets
Go back to Cerus Announces the Inclusion of Pathogen Reduction Technology in FDA’s Revised Guidance Document on Bacterial Safety Standards for Platelets| Cerus Corp (NASDAQ: CERS) | Delayed: 2.64 +0.05 (1.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.59 | 52 Week High | $7.64 | |||
| Open | $2.57 | 52 Week Low | $4.22 | |||
| Day High | $2.65 | P/E | N/A | |||
| Day Low | $2.56 | EPS | $-0.59 | |||
| Volume | 2,784,569 | |||||
